TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal Spring weather is finally here, making Read more…
It has been what felt like a few years since the previous FOMC, with what resembles a totally different Market since. Since January 28, Oil is up close to 60%, Silver is down 25%, previously Read more…
The Federal Reserve is expected to deliver a “hawkish hold.” The Summary of Economic Projections (SEP) is anticipated to show higher inflation forecasts and a risk that the one expected 2026 rate cut could be Read more…
The USD/JPY pair is trading around 158.90, facing a high risk of FX intervention by the Japanese Ministry of Finance as it nears the 160.00 level. The week is dominated by a “central bank double-header,” Read more…
Welcome to a more unusual Market update to show what could be a significant development for Markets for periods ahead. WTI Crude Oil is forming a Head & Shoulders ahead of the FOMC meeting, a Read more…
Gold price remains at the back foot on Tuesday and continues to pressure key $5000 support zone (recent range floor / psychological / top of thin ascending daily cloud) after Monday’s attack failed to register Read more…
For three years, rising mortgage rates and elevated home prices locked millions of would-be buyers out of the market. Monthly payments climbed, budgets shrank, and starter homes slipped out of reach. Now, a shift is Read more…
AUDJPY: ⬆️ Buy AUDJPY reversed from support area Likely to rise to resistance level 114.00 AUDJPY recently reversed from the support area between the support level 111.45 (former resistance from February), 20-day moving average and Read more…
The furniture retail sector has suffered from economic distress in the last year with major home furnishing companies closing stores and filing for bankruptcy protection. Companies that have filed for bankruptcy include AFC Acquisition Corp., Read more…
Eli Lilly has spent the last decade transforming from a reliable but unremarkable dividend payer into one of the most talked-about stocks on Wall Street. Its obesity and diabetes franchise, built around tirzepatide, the active Read more…